• Amyloid Beta-Peptide (1-40) (human): Advanced Workflows for

  2026-05-16

  Amyloid Beta-Peptide (1-40) (human) from APExBIO empowers precise modeling of amyloid aggregation and neurotoxicity, uniquely supporting both mechanistic studies and translational applications in Alzheimer’s disease research. Explore advanced workflows, troubleshooting tactics, and insights from recent discoveries that redefine how this peptide informs neurodegeneration studies.

• In Vitro Susceptibility of Staphylococci to Mupirocin and No

  2026-05-15

  This study evaluates the in vitro activity of mupirocin and novobiocin against meticillin-resistant and meticillin-susceptible staphylococci from dogs, highlighting key resistance trends and methodology. Its findings inform antimicrobial selection for veterinary dermatology and provide a comparative framework for in vitro antibacterial testing strategies.

• Merimepodib (VX-497): Precision IMPDH Inhibition in Antivira

  2026-05-15

  Merimepodib (VX-497) empowers researchers to selectively target guanine nucleotide biosynthesis, delivering robust inhibition of cell proliferation and viral replication. With validated, cross-species efficacy and unique workflow flexibility, it unlocks new possibilities for cancer, immunology, and virology experiments—especially where specificity and reversibility are critical.

• N3-kethoxal: Precision Mapping of RNA Structures and Genomic

  2026-05-14

  N3-kethoxal, a membrane-permeable azide-functionalized nucleic acid probe, enables high-resolution, covalent labeling of unpaired guanine bases in both RNA and DNA for advanced structural and functional genomic studies. Its versatility spans in vitro and live-cell assays, supporting cutting-edge applications from RNA secondary structure probing to direct mapping of accessible genomic DNA. This article provides proven workflows, troubleshooting strategies, and evidence-based protocol parameters to maximize assay reliability and reproducibility.

• Paclitaxel (Taxol): Defining Selectivity and Potency in Canc

  2026-05-14

  Explore how Paclitaxel (Taxol) delivers unmatched selectivity and potency in cancer research, with a unique focus on assay precision and translational impact. Discover how its mechanistic clarity and validated parameters set the gold standard for experimental design.

• Autophagy–Metastasis Prognostic Signature in Colorectal Canc

  2026-05-13

  Bai et al. (2026) developed and validated a prognostic signature comprising six genes related to autophagy and liver metastasis in colorectal cancer. Integrating bulk and single-cell transcriptomics, this signature predicts clinical outcomes, immune microenvironment remodeling, and potential therapeutic resistance, advancing precision oncology for CRC patients.

• HyperScribe Co-transcription mRNA Synthesis Kit Plus: Reliab

  2026-05-13

  This article addresses common laboratory challenges in mRNA synthesis, focusing on workflow reliability, translational efficiency, and data reproducibility. Using scenario-driven Q&A, we demonstrate how the HyperScribe™ Co-transcription mRNA Synthesis Kit Plus (ARCA, T7) (SKU K1406) offers robust, evidence-backed solutions for advanced RNA research, including RNA vaccine development and in vitro translation assays.

• Chlorpromazine HCl: Translational Leverage Beyond Dopamine

  2026-05-12

  This thought-leadership article explores how Chlorpromazine HCl, a phenothiazine dopamine receptor antagonist, not only advances psychotic disorder research but also emerges as a tool for host-directed antibacterial strategies. Drawing on recent mechanistic evidence, we guide translational researchers in leveraging Chlorpromazine HCl for both neuropharmacology and innovative infection models, highlighting APExBIO’s leading role in supplying research-grade compounds.

• Technical Guidance for Angiotensin I/II (1-5) in RAS Researc

  2026-05-12

  Angiotensin I/II (1-5) provides the defined Asp-Arg-Val-Tyr-Ile peptide fragment essential for modeling blood pressure regulation and aldosterone stimulation within the renin-angiotensin system. It is appropriate for cardiovascular and renal workflows, but should not be used outside these research contexts. Adherence to its solubility and storage requirements is critical for reproducibility.

• Chlorpromazine HCl: Mechanistic Insight for Translational Re

  2026-05-11

  Explore how Chlorpromazine HCl, a classic dopamine receptor antagonist, enables advanced translational research across neuropharmacology and infection models. This article offers mechanistic depth, evidence-based guidance, and strategic context—bridging foundational neuroscience with host-pathogen investigations. It also positions APExBIO’s Chlorpromazine HCl as a benchmark reagent for experimental rigor and cross-domain innovation.

• Intestinal TM6SF2 Modulates Gut–Liver Axis to Prevent MASH

  2026-05-11

  This study identifies intestinal TM6SF2 as a key regulator that protects against metabolic dysfunction-associated steatohepatitis (MASH) by maintaining gut barrier integrity and modulating lipid-driven gut–liver signaling. The findings suggest that targeting intestinal lipid handling and LPA signaling may offer new therapeutic avenues for MASH.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor In

  2026-05-10

  Wang et al. (2018) systematically analyzed the entry mechanism of genotype III grass carp reovirus (GCRV104) in host cells, identifying clathrin-mediated, pH-dependent endocytosis as essential for infection. Their pharmacological inhibitor screen clarified which pathways are critical for viral entry, informing targeted research into host-virus interactions in aquaculture virology.

• Scenario-Driven Solutions with JNK-IN-7 in Apoptosis Assays

  2026-05-09

  This article uses five real laboratory scenarios to illustrate how JNK-IN-7 (SKU A3519) delivers reproducible, data-backed results in cell viability and apoptosis assays. Learn why researchers trust this selective JNK inhibitor for MAPK pathway studies, with evidence-based guidance and direct comparison to alternatives.

• Applied Workflows with Protoporphyrin IX: Photodynamic Compo

  2026-05-09

  Protoporphyrin IX is not just a heme biosynthetic intermediate—it is a cornerstone for advanced photodynamic cancer diagnosis and ferroptosis research. Discover evidence-backed, stepwise protocols, troubleshooting tips, and the latest innovations, including practical translation from the METTL16-SENP3-LTF axis study, to optimize your experimental outcomes with APExBIO’s high-purity reagent.

• Macrophage M1 Polarization via TLR4 in Colitis-Linked Cancer

  2026-05-08

  Liu et al. reveal that Jiedu Xiaozheng Yin (JXY) suppresses colitis-associated colorectal cancer progression by promoting macrophage polarization toward the anti-tumorigenic M1 phenotype through the TLR4 pathway. This work highlights the relevance of immune microenvironment modulation for chemopreventive strategies and provides data-driven insight into pathway-specific interventions.

15625 records 1/1042 page Next 12345 下5页 Last page